VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CLDX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CLDXCelldex Therapeutics, Inc.
$29.87$2.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCLDXQuarterly Balance Sheet

Celldex Therapeutics, Inc. (CLDX) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Celldex Therapeutics, Inc. (CLDX) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

CLDX Balance Sheet

Quarterly statement

CLDX Balance Sheet

Celldex Therapeutics, Inc. (CLDX) balance sheet — 30-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Total Current Assets663.74M724.93M459.22M534.66M604.34M648.4M693.76M747.16M778.84M811.98M835.32M431.69M245.93M264.82M289.6M317.69M334.6M367.98M390.7M410.84M
Cash & Short-Term Investments650.32M717.59M451.46M518.57M583.22M630.34M673.29M725.28M756M802.32M823.85M421.7M235.35M252.7M278.39M304.95M323.47M356.82M380.47M408.25M
Cash Only26.95M47.45M35.73M28.87M36.04M23.04M17.14M28.36M36.4M42.74M115.08M34.81M21.13M28.22M54.12M29.43M18.58M28.4M25.29M39.14M
Short-Term Investments623.37M670.13M415.73M489.7M547.19M607.29M656.15M696.92M719.6M759.58M708.77M386.88M214.21M224.47M224.26M275.52M304.89M328.42M355.18M369.11M
Accounts Receivable355K230K230K2.02M90K90K1.06M700K852K1.53M2.67M4.53M252K118K1.31M347K189K97K243K172K
Days Sales Outstanding-951.366.74K1.29K-71.93114.2260.7634.476.592.1K53.2311.22243.1277.315.2932.3294.91107.3350.82
Inventory00000000000000000000
Days Inventory Outstanding--------------------
Other Current Assets007.53M14.08M21.03M17.98M19.4M21.18M21.99M8.12M05.47M00000000
Total Non-Current Assets57.8M57.42M52.03M48.32M44.1M44M45.71M45.18M44.34M33.61M33.52M33.93M34.32M34.49M34.92M35.04M34.63M34.98M33.34M33.81M
Property, Plant & Equipment20.92M14.79M9.41M7.77M7.55M7.51M8.12M8.24M7.4M6.31M6.23M6.64M7.03M7.19M7.63M7.75M7.33M7.69M6.05M6.52M
Fixed Asset Turnover-0.00x0.00x0.01x-0.09x0.08x0.15x0.47x0.40x0.02x0.60x0.21x0.04x0.13x0.21x0.05x0.02x0.03x0.05x
Goodwill00000000000000000000
Intangible Assets27.19M27.19M27.19M27.19M27.19M27.19M27.19M27.19M27.19M27.19M27.19M27.19M27.19M27.19M27.19M27.19M27.19M27.19M27.19M27.19M
Long-Term Investments00000000000000000000
Other Non-Current Assets9.69M15.43M15.43M13.36M9.36M9.3M10.41M9.75M9.75M107K107K107K107K107K104K104K104K104K104K104K
Total Assets721.53M782.35M511.25M582.98M648.44M692.41M739.47M792.34M823.18M845.59M868.85M465.63M280.26M299.31M324.52M352.74M369.23M402.96M424.04M444.65M
Asset Turnover-0.00x0.00x0.00x-0.00x0.00x0.00x0.00x0.00x0.00x0.01x0.01x0.00x0.00x0.00x0.00x0.00x0.00x0.00x
Asset Growth %11.27%12.99%-30.86%-26.42%-21.23%-18.12%-14.89%70.17%193.72%182.51%167.73%32%-24.1%-25.72%-23.47%-20.67%-19.77%97%93.57%88.54%
Total Current Liabilities60.52M61.33M51.47M50.99M46.47M32.96M32.02M39.5M32.09M27.66M26.29M31.13M27.84M15.65M15.22M18.61M16.29M29.95M14.56M16.53M
Accounts Payable11.24M14.68M10.36M1.18M4.27M2.07M3.41M3.27M1.11M3.8M3.23M3.49M3.59M881K3.37M3.34M2.27M902K1.02M1.23M
Days Payables Outstanding14.49-608.03-4.634.65.71245.955401.6839510.7267.97.3711.2711.276.774.225.936.47
Short-Term Debt00000000000000000000
Deferred Revenue (Current)00000000000000000000
Other Current Liabilities1.23M01.23M1.23M930K930K1.65M942K1.4M3.67M3.88M3.99M4.23M978K978K990K1.15M1.39M2.5M1.55M
Current Ratio10.97x11.82x8.92x10.49x13.01x19.67x21.67x18.91x24.27x29.36x31.77x13.87x8.84x16.93x19.03x17.07x20.54x12.29x26.83x24.86x
Quick Ratio10.97x11.82x8.92x10.49x13.01x19.67x21.67x18.91x24.27x29.36x31.77x13.87x8.84x16.93x19.03x17.07x20.54x12.29x26.83x24.86x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities11.54M6.46M3.56M4.83M3.61M4.04M4.47M5.83M5.18M4.27M3.94M5.33M5.7M6.13M6.56M7.92M7.52M7.92M11.38M8.65M
Long-Term Debt00443K00000000000000000
Capital Lease Obligations8.43M3.35M0784K1.07M1.5M1.93M2.36M1.71M796K470K928K1.3M1.73M2.16M2.59M2.19M2.59M841K1.3M
Deferred Tax Liabilities1.61M0000000000000000000
Other Non-Current Liabilities1.5M3.11M3.11M4.04M2.54M2.54M2.54M3.47M3.47M3.47M3.47M4.4M4.4M4.4M4.4M5.33M5.33M5.33M10.54M7.35M
Total Liabilities72.06M67.78M55.03M55.82M50.08M37M36.49M45.34M37.27M31.93M30.23M36.46M33.54M21.77M21.78M26.53M23.81M37.87M25.94M25.18M
Total Debt9.87M4.9M1.91M2.34M2.62M3.03M3.43M3.81M3.09M2.38M2.11M2.54M2.85M3.25M3.65M4.03M3.63M4.01M2.64M3.04M
Net Debt-17.08M-42.55M-33.82M-26.54M-33.42M-20.01M-13.71M-24.54M-33.31M-40.35M-112.96M-32.27M-18.29M-24.97M-50.47M-25.4M-14.96M-24.39M-22.65M-36.1M
Debt / Equity0.02x0.01x0.00x0.00x0.00x0.00x0.00x0.01x0.00x0.00x0.00x0.01x0.01x0.01x0.01x0.01x0.01x0.01x0.01x0.01x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage------------11.29x--------
Total Equity649.47M714.56M456.23M527.16M598.36M655.41M702.98M747M785.9M813.66M838.61M429.17M246.72M277.54M302.74M326.2M345.42M365.09M398.1M419.48M
Equity Growth %8.54%9.03%-35.1%-29.43%-23.86%-19.45%-16.17%74.06%218.54%193.17%177.01%31.57%-28.57%-23.98%-23.95%-22.24%-20.91%100.29%105.03%100.36%
Book Value per Share8.279.186.857.939.019.8710.5911.2611.8512.3214.248.255.225.876.416.927.367.818.528.98
Total Shareholders' Equity649.47M714.56M456.23M527.16M598.36M655.41M702.98M747M785.9M813.66M838.61M429.17M246.72M277.54M302.74M326.2M345.42M365.09M398.1M419.48M
Common Stock79K79K67K67K66K66K66K66K66K66K66K56K47K47K47K47K47K47K47K47K
Retained Earnings-2.04B-1.97B-1.89B-1.81B-1.73B-1.67B-1.61B-1.56B-1.51B-1.47B-1.43B-1.4B-1.35B-1.32B-1.29B-1.26B-1.23B-1.2B-1.17B-1.14B
Treasury Stock00000000000000000000
Accumulated OCI-329K1.3M2.52M3.63M3.77M3.34M3.57M3.31M5.29M1.78M2.24M3.31M2.13M2.07M2.12M1.26M-112K-417K112K1.89M
Minority Interest00000000000000000000